Addex Therapeutics corrects Hill grant to 1.32M options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Addex Therapeutics Ltd. director Raymond George Hill received a corrected grant of 1,319,996 stock options on November 11, 2026, replacing the 942,854 options reported originally. The options vest in equal monthly installments over four years beginning on the exercisable date, carry a U.S.-dollar exercise price of $0.0260 per share, and expire November 10, 2036. The reported post-transaction option position was 1,593,103 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock-option (Right to Buy) F1, F3, F2 | 1,319,996 | $0.00 | $0.00 |
Footnotes (3)
- F1. This form 4/A is being filed to correct the number of stock-options reported as granted in the original Form 4 filed on November 13, 2026. The original filing incorrectly reported 942,854 stock-options granted. The correct number of stock-options granted on November 11, 2026 is 1,319,996.
- F2. The stock-options vest on equal monthly installments over a 4-year period beginning at the exercisable date. Each stock-option grants to right to purchase one ADXN share listed on SIX Swiss Exchange.
- F3. The exercise price is reported in U.S. dollars and reflects the conversion from CHF to USD at an exchange rate of $ 1.1995 per CHF 1.00 as of November 11, 2026.
Key Figures
Key Terms
stock-options financial
equal monthly installments technical
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many stock options did Addex director Raymond George Hill receive?
What can Raymond George Hill purchase with each Addex option?
AI-generated analysis. How Rhea-AI works. Not financial advice.